[144] Vistra Corp. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Vistra Corp. (VST) reports a proposed sale of 21,361 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $4,540,506.03 and an approximate sale date of 09/17/2025. The filer indicates the shares were acquired on 09/17/2025 upon exercise of options originally granted on 10/11/2016 (19,200 shares) and 04/09/2018 (2,161 shares) and that payment was in cash. The filing also lists recent sales by James A. Burke totaling five transactions between 09/10/2025 and 09/16/2025 with reported gross proceeds on each trade.

Positive

• Complete transactional details provided including broker, share counts, acquisition dates, and payment method
• Recent sale history disclosed with dates and gross proceeds for five transactions, improving transparency
• Seller attests to absence of undisclosed material adverse information and cites Rule 10b5-1 language

Negative

• Filer identity fields appear incomplete in the supplied extract (CIK/CCC and contact details not shown)
• No explicit signature, dates of notice or plan-adoption date are present in the extract, which are typically required for full context

Insights

Securities Analyst

TL;DR: Insider plans to sell 21,361 shares (≈$4.54M) via brokerage after exercising options; recent related sales occurred earlier in the week.

The filing documents a routine Section 144 notice by an insider or person associated with Vistra Corp. The shares to be sold equal the exercised option shares (19,200 and 2,161) and the sale is to occur on the NYSE through Fidelity. The timing and amounts align with standard Rule 144 disclosures for restricted or control securities following option exercise. Reported recent sales by James A. Burke on five dates provide context that related divestitures have already occurred earlier in the week, indicating a sequence of sales rather than a single isolated transaction.

Compliance/Risk Analyst

TL;DR: Disclosure appears compliant with Rule 144; signer affirms no undisclosed material information and notes cash payment for exercised options.

The form includes acquisition details, nature of acquisition (option grants), payment method (cash), broker information, and recent sales history, which satisfy typical Form 144 content requirements. The signature remarks section reiterates the representation that the seller is unaware of undisclosed material adverse information and references Rule 10b5-1 where applicable. No explicit compliance exceptions or incomplete mandatory fields are evident in the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21361	4540506.03	338820324	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/17/2025	Option Granted - 10/11/2016	issuer			19200	09/17/2025	Cash
Common	09/17/2025	Option Granted - 04/09/2018	Issuer			2161	09/17/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/10/2025	19592	3933635.75
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/11/2025	43074	8991625.77
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/12/2025	21374	4335603.72
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/15/2025	21362	4481773.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/16/2025	21358	4565882.35

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Vistra Corp. (VST) disclose?

The Form 144 discloses a proposed sale of 21,361 common shares via Fidelity on the NYSE with an aggregate market value of $4,540,506.03 and an approximate sale date of 09/17/2025.

How were the shares being sold acquired according to the filing?

The shares were acquired upon exercise of options: 19,200 from an option granted 10/11/2016 and 2,161 from an option granted 04/09/2018, with payment in cash on 09/17/2025.

Who executed recent related sales and when were they made?

James A. Burke executed five sales on 09/10/2025, 09/11/2025, 09/12/2025, 09/15/2025, and 09/16/2025, with gross proceeds reported for each transaction.

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through Fidelity Brokerage Services LLC located at 900 Salem Street, Smithfield, RI, and the securities exchange is listed as the NYSE.

Does the filing state whether the seller knows of any undisclosed material information?

Yes. By signing the notice the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.